Argenx (ticker: ARGX) — a Dutch biopharmaceutical company specializing in the development of innovative antibodies for the treatment of autoimmune diseases. Founded in 2008, the company has established itself as a leader in immunology.
Disclaimer
All content provided on this website (https://wildinwest.com/) -including attachments, links, or referenced materials — is for informative and entertainment purposes only and should not be considered as financial advice. Third-party materials remain the property of their respective owners.